Senior Manager, Regulatory Operations jobs in United States
cer-icon
Apply on Employer Site
company-logo

Immunome, Inc. · 2 days ago

Senior Manager, Regulatory Operations

Immunome is a clinical-stage targeted oncology company dedicated to developing innovative cancer therapies. The Senior Manager, Regulatory Operations will lead regulatory systems and submission processes for clinical-stage oncology programs, ensuring compliance with global regulatory requirements.

BiopharmaBiotechnologyMedicalPharmaceutical

Responsibilities

Lead the planning, formatting, publishing, and submission of global regulatory documents, including INDs, amendments, annual reports, meeting packages, and eCTD submissions
Manage document workflows, version control, and archival processes to maintain complete and compliant regulatory records
Partner with cross-functional teams to ensure timely delivery of submission components and adherence to regulatory standards
Oversee regulatory submission timelines, identifying risks and implementing mitigation strategies
Maintain and enhance regulatory systems, including EDMS, RIM, and publishing tools
Coordinate Health Authority meeting logistics and regulatory documentation
Support development of SOPs, templates, and process improvements
Ensure submissions comply with FDA, EMA, ICH, and other global regulations

Qualification

Regulatory operations experienceECTD submissionsRegulatory publishing toolsGlobal regulatory frameworksOncology development programsProject managementCommunication skillsCollaborationDetail-oriented

Required

Bachelor's degree in a scientific or related discipline is required
A minimum of 5 years of regulatory operations experience in the biotechnology or pharmaceutical industry
Demonstrated experience preparing and publishing eCTD submissions
Strong understanding of global regulatory frameworks and submission standards
Expertise with regulatory publishing tools and regulatory information management systems
Strong organizational, project management, and communication skills
Proven ability to collaborate effectively across functional teams
Detail-oriented with a commitment to high-quality documentation and compliance

Preferred

Experience supporting oncology development programs is preferred

Company

Immunome, Inc.

twittertwittertwitter
company-logo
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients.

Funding

Current Stage
Public Company
Total Funding
$998.85M
Key Investors
JPEO-CBRNDU.S. Department of DefenseRobin Hood Ventures
2025-12-16Post Ipo Equity· $400M
2025-01-29Post Ipo Equity· $150M
2024-02-13Post Ipo Equity· $230M

Leadership Team

leader-logo
Clay Siegall
President and CEO
linkedin
leader-logo
Purnanand D. Sarma
President & CEO
linkedin

Recent News

BioWorld Financial Watch
Company data provided by crunchbase